![](/img/cover-not-exists.png)
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V McCloskey, Helena Johansson, Anders Oden, Matt Austin, Ethel Siris, Andrea Wang, E Michael Lewiecki, Roman Lorenc, Cesar Libanati, John A KanisVolume:
27
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/jbmr.1606
File:
PDF, 158 KB
english, 2012